Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells

Nat Commun. 2019 Sep 27;10(1):4401. doi: 10.1038/s41467-019-12319-x.

Abstract

Tissue-resident memory CD8+ T (Trm) cells mediate potent local innate and adaptive immune responses and play a central role against solid tumors. However, whether Trm cells cross-talk with dendritic cells (DCs) to support anti-tumor immunity remains unclear. Here we show that antigen-specific activation of skin Trm cells leads to maturation and migration to draining lymph nodes of cross-presenting dermal DCs. Tumor rejection mediated by Trm cells triggers the spread of cytotoxic CD8+ T cell responses against tumor-derived neo- and self-antigens via dermal DCs. These responses suppress the growth of intradermal tumors and disseminated melanoma lacking the Trm cell-targeted epitope. Moreover, analysis of RNA sequencing data from human melanoma tumors reveals that enrichment of a Trm cell gene signature associates with DC activation and improved survival. This work unveils the ability of Trm cells to amplify the breath of cytotoxic CD8+ T cell responses through DCs, thereby strengthening anti-tumor immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Cell Movement / immunology
  • Cross-Priming / immunology
  • Dendritic Cells / immunology*
  • Humans
  • Immunologic Memory / immunology*
  • Lymph Nodes / immunology
  • Melanoma / immunology*
  • Melanoma / pathology
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Skin / cytology
  • Skin / immunology*
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Antigens